<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2025-4-919-929</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2823</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORT</subject></subj-group></article-categories><title-group><article-title>Важность нутрицевтической поддержки по протоколу AREDS2 при возрастной макулярной дегенерации: клиническое наблюдение</article-title><trans-title-group xml:lang="en"><trans-title>The Importance of Nutraceutical Support According to the AREDS2 Protocol in Age-related Macular Degeneration. Clinical observation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малахова</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Malakhova</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малахова Анна Ивановна - кандидат медицинских наук, врач-офтальмолог, главный внештатный офтальмолог Министерства здравоохранения Смоленской области.</p><p>Пр-т Гагарина, 27, Смоленск, 214018</p></bio><bio xml:lang="en"><p>Malakhova Anna I. - PhD, ophthalmologist, chief ophthalmologist of the Ministry of Health of the Smolensk Region.</p><p>Gagarina ave., 27, Smolensk, 214018</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ОГБУЗ «Смоленская областная клиническая больница»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Care Smolensk Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2025</year></pub-date><volume>22</volume><issue>4</issue><fpage>919</fpage><lpage>929</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Малахова А.И., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Малахова А.И.</copyright-holder><copyright-holder xml:lang="en">Malakhova A.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2823">https://www.ophthalmojournal.com/opht/article/view/2823</self-uri><abstract><p>Каротиноиды, входящие в состав макулярного пигмента, играют ключевую роль в поддержании зрительных функций. Возрастные изменения органа зрения диктуют необходимость повышенного поступления витаминов и минеральных веществ для замедления дегенеративных процессов в сетчатке. Оптимальными для замедления развития поздних стадий возрастной макулярной дегенерации (ВМД) признаны витаминно-минеральные комплексы (ВМК), содержащие лютеин, зеаксантин и антиоксиданты, что подтверждено международными исследованиями. Мультифокальная электроретинография (мфЭРГ) представляет интерес как метод объективной оценки функции сетчатки и является одним из чувствительных биомаркеров тяжести и прогрессирования заболевания. В статье представлены клинические примеры использования объективной методики мфЭРГ в оценке действия ВМК на клетки сетчатки.</p></abstract><trans-abstract xml:lang="en"><p>Carotenoids, which are part of macular pigment, play a key role in maintaining visual functions. Age-related changes in the visual organ necessitate increased intake of vitamins and minerals to slow down degenerative processes in the retina. Vitamin and mineral complexes (VMC) containing lutein, zeaxanthin, and antioxidants have been proven to be effective in slowing down the progression of advanced AMD, as evidenced by international studies. Multifocal electroretinogram (mFERG) is of interest as a method of objective assessment of retinal function and is one of the sensitive biomarkers of severity and progression of the disease. The article presents clinical examples of the use of the objective mFERG technique in assessing the effect of VMC on retinal cells.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лютеин</kwd><kwd>антиоксиданты</kwd><kwd>каротиноиды</kwd><kwd>мультифокальная электроретинограмма</kwd><kwd>витамины</kwd><kwd>сетчатка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lutein</kwd><kwd>antioxidants</kwd><kwd>carotenoids</kwd><kwd>multifocal</kwd><kwd>electroretinogram</kwd><kwd>vitamins</kwd><kwd>retina</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Материал подготовлен при поддержке компании ООО «Бауш Хелс». Позиция автора статьи может отличаться от позиции компании ООО «Бауш Хелс»</funding-statement><funding-statement xml:lang="en">The material was prepared with the support of Bausch Health LLC. The position of the authors of the article may differ from the position of Bausch Health LLC</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Нутрициология и клиническая диетология: национальное руководство / под ред. В.А. Тутельяна, Д.Б. Никитюка. М.: ГЭОТАР-Медиа, 2020:656.</mixed-citation><mixed-citation xml:lang="en">Nutrition and clinical dietetics. National guidelines. Tutelyan V.A., Nikityuk D.B., eds. Moscow: GEOTAR-Media; 2020:656 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Коденцова ВМ, Вржесинская ОА, Рисник ДВ. Обеспеченность населения России микронутриентами и возможности ее коррекции. Состояние проблемы. Вопросы питания. 2017;86(4):113–124. doi: 10.24411/0042-88332017-00067.</mixed-citation><mixed-citation xml:lang="en">Kodentsova VM, Vrzhesinskaya OA, Risnik DV. Provision of the Russian population with micronutrients and possibilities of its correction. State of the problem. Problems of Nutrition. 2017;86(4):113–124 (In Russ.). doi: 10.24411/0042-88332017-00067.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Skoblina N. Eye health risks associated with the use of electronic devices and awareness of youth. Klinika Oczna. Acta Ophthalmologica Polonica. 2020;2:60–65.</mixed-citation><mixed-citation xml:lang="en">Skoblina N. Eye health risks associated with the use of electronic devices and awareness of youth. Klinika Oczna. Acta Ophthalmologica Polonica. 2020;2:60–65.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ушаков ИБ, Попов ВИ, Скоблина НА, Маркелова СВ. Длительность использования мобильных электронных устройств как современный фактор риска здоровью детей, подростков и молодежи. Экология человека. 2021;7:43–50.</mixed-citation><mixed-citation xml:lang="en">Ushakov IB, Popov VI, Skoblina NA, Markelova SV. Duration of use of mobile electronic devices as a modern risk factor for the health of children, adolescents and young people. Human ecology. 2021;7:43–50 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Студеникин ВМ, Спиричев ВБ, Самсонова ТВ. Влияние дополнительной витаминизации на заболеваемость и когнитивные функции у детей. Вопросы детской диетологии. 2009;7(3):32–37.</mixed-citation><mixed-citation xml:lang="en">Studenikin VM, Spirichev VB, Samsonova TV. Influence of supplementary vitamins donation on morbidity and cognitive functions in children. Problems of pediatric nutritiology. 2009;7(3):32–37 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">NIH study confirms benefit of supplements for slowing age-related macular degeneration https://www.nih.gov/news-events/news-releases/nih-study-confirmsbenefit-supplements-slowing-age-related-macular-degeneration (дата обращения: 10.09.2024).</mixed-citation><mixed-citation xml:lang="en">NIH study confirms benefit of supplements for slowing age-related macular degeneration https://www.nih.gov/news-events/news-releases/nih-study-confirmsbenefit-supplements-slowing-age-related-macular-degeneration (дата обращения: 10.09.2024).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Кирпиченкова ЕВ. Изучение содержания лютеина и зеаксантина в рационе с оценкой взаимосвязи уровня алиментарного поступления невитаминных каротиноидов и плотности макулярной области сетчатки в молодом возрасте. Вопросы питания. 2018:87(5):20–26.</mixed-citation><mixed-citation xml:lang="en">Kirpichenkova EV. Study of the content of lutein and zeaxanthin in the diet with an assessment of the relationship between the level of alimentary intake of nonvitamin carotenoids and the density of the macular region of the retina at a young age. Рroblems of nutrition. 2018;87(5): 20–26 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, Cougnard-Gregoire A, Merle BMJ, Korb C, Erke MG, Bron A, Anastesopoulos E, Meester-Smoor MA, Segato T, Piermacocchi S, de Jong PTVM, Vingerling JR, Topouzis F, Creuzot-Garcher C, Bettelsen G, Preiffer N, Fletcher AE, Foster PJ, Silva R, Korobelnik J-F, Delcourt C, Klever CCW. Prevalence of age-related macular degeneration in Europe. The past and the future. Ophthalmology. 2017;124(12):1753–1763. doi: 10.1016/j.ophtha.2017.05.035.</mixed-citation><mixed-citation xml:lang="en">Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, Cougnard-Gregoire A, Merle BMJ, Korb C, Erke MG, Bron A, Anastesopoulos E, Meester-Smoor MA, Segato T, Piermacocchi S, de Jong PTVM, Vingerling JR, Topouzis F, Creuzot-Garcher C, Bettelsen G, Preiffer N, Fletcher AE, Foster PJ, Silva R, Korobelnik J-F, Delcourt C, Klever CCW. Prevalence of age-related macular degeneration in Europe. The past and the future. Ophthalmology. 2017;124(12):1753–1763. doi: 10.1016/j.ophtha.2017.05.035.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнова ТВ, Будзинская МВ, Шелудченко ВМ. Мультифокальная электроретинография в диагностике и мониторинге ранней и промежуточной стадий возрастной макулярной дегенерации. Вестник офтальмологии. 2024;140(2-2):172–179. doi: 10.17116/oftalma2024140022172.</mixed-citation><mixed-citation xml:lang="en">Smirnova TV, Budzinskaya MV, Sheludchenko VM. Multifocal electroretinography in the diagnosis and monitoring of early and intermediate stages of age-related macular degeneration. Russian Annals of Ophthalmology. 2024;140(2.2):172–179 (In Russ.). doi: 10.17116/oftalma2024140022172.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Delcourt C, Carrière I, Delage M, Barberger-Gateau P, Schalch W; POLA Study Group. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2329–2335. doi: 10.1167/iovs.05-1235.</mixed-citation><mixed-citation xml:lang="en">Delcourt C, Carrière I, Delage M, Barberger-Gateau P, Schalch W; POLA Study Group. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2329–2335. doi: 10.1167/iovs.05-1235.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001 Oct;119(10):1439–1452. doi: 10.1001/archopht.119.10.1439.</mixed-citation><mixed-citation xml:lang="en">Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001 Oct;119(10):1439–1452. doi: 10.1001/archopht.119.10.1439.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Parmar UPS. Antioxidants in Age-Related Macular Degeneration: Lights and Shadows. Antioxidants. 2025;14:152. doi: 10.3390/antiox14020152.</mixed-citation><mixed-citation xml:lang="en">Parmar UPS. Antioxidants in Age-Related Macular Degeneration: Lights and Shadows. Antioxidants. 2025;14:152. doi: 10.3390/antiox14020152.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации «Возрастная макулярная дегенерация», 2024.</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines “Age-related macular degeneration”, 2024.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR. Beckman Initiative for Macular Research Classification Committee. Clinical classification of age-related macular degeneration. 2013 Apr;120(4):844–851. doi: 10.1016/j.ophtha.2012.10.036.</mixed-citation><mixed-citation xml:lang="en">Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR. Beckman Initiative for Macular Research Classification Committee. Clinical classification of age-related macular degeneration. 2013 Apr;120(4):844–851. doi: 10.1016/j.ophtha.2012.10.036.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY. Age-Related Eye Disease Study 2 Research Group. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology 2019 Feb;126(2):261–273. doi: 10.1016/j.ophtha.2018.08.017.</mixed-citation><mixed-citation xml:lang="en">Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY. Age-Related Eye Disease Study 2 Research Group. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology 2019 Feb;126(2):261–273. doi: 10.1016/j.ophtha.2018.08.017.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Curcio CA. Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies. Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD160–AMD181. doi: 10.1167/iovs.18-24882.</mixed-citation><mixed-citation xml:lang="en">Curcio CA. Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies. Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD160–AMD181. doi: 10.1167/iovs.18-24882.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hayashi R, Hayashi S, Machida S. Changes in Macular Pigment Optical Density among Pseudophakic Patients following Intake of a Lutein-Containing Supplement. Ophthalmic Res. 2021;64(5):828–836. doi: 10.1159/000517573.</mixed-citation><mixed-citation xml:lang="en">Hayashi R, Hayashi S, Machida S. Changes in Macular Pigment Optical Density among Pseudophakic Patients following Intake of a Lutein-Containing Supplement. Ophthalmic Res. 2021;64(5):828–836. doi: 10.1159/000517573.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenthal JM, Kim J, de Monasterio F, Thompson DJ, Bone RA, Landrum JT, de Moura FF, Khachik F, Chen H, Schleicher RL, Ferris FL 3rd, Chew EY. Dose-ranging study of lutein supplementation in persons aged 60 years or older. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5227–5233. doi: 10.1167/iovs.05-1513.</mixed-citation><mixed-citation xml:lang="en">Rosenthal JM, Kim J, de Monasterio F, Thompson DJ, Bone RA, Landrum JT, de Moura FF, Khachik F, Chen H, Schleicher RL, Ferris FL 3rd, Chew EY. Dose-ranging study of lutein supplementation in persons aged 60 years or older. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5227–5233. doi: 10.1167/iovs.05-1513.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Педанова ЕК. Нутрицевтики при возрастной макулярной дегенерации: оптимизация состава с прицелом на безопасность. Офтальмология. 2022;19(1):179–187. doi: 10.18008/1816-5095-2022-1-179-187.</mixed-citation><mixed-citation xml:lang="en">Pedanova EK. Nutraceuticals for Age-Related Macular Degeneration: Formulation Optimization Focused on Safety. Ophthalmology in Russia. 2022;19(1):179–187 (In Russ.). doi: 10.18008/1816-5095-2022-1-179-187.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Landrum JT, Bone RA, Lutein, zeaxanthin, and the macular pigment, Arch. Biochem. Biophys. 2001;385:28–40. doi: 10.1006/abbi.2000.2171.</mixed-citation><mixed-citation xml:lang="en">Landrum JT, Bone RA, Lutein, zeaxanthin, and the macular pigment, Arch. Biochem. Biophys. 2001;385:28–40. doi: 10.1006/abbi.2000.2171.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Arunkumar R, Gorusupudi A, Bernstein PS. The macular carotenoids: A biochemical overview. Biochimica et Biophysica Acta (BBA) — Molecular and Cell Biology of Lipids. 2020;1865(11):158617. doi: 10.1016/j.bbalip.2020.158617.</mixed-citation><mixed-citation xml:lang="en">Arunkumar R, Gorusupudi A, Bernstein PS. The macular carotenoids: A biochemical overview. Biochimica et Biophysica Acta (BBA) — Molecular and Cell Biology of Lipids. 2020;1865(11):158617. doi: 10.1016/j.bbalip.2020.158617.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">AREDS2 Research Group; Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012 Nov;119(11):2282–2289. doi: 10.1016/j.ophtha.2012.05.027.</mixed-citation><mixed-citation xml:lang="en">AREDS2 Research Group; Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012 Nov;119(11):2282–2289. doi: 10.1016/j.ophtha.2012.05.027.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Shyam R, Gorusupudi A, Nelson K. Horvath MP. Bernstein PS. RPE65 has an additional function as the lutein to meso-zeaxanthin isomerase in the vertebrate eye. Proc. Natl. Acad. Sci. USA. 2017;114:10882–10887.</mixed-citation><mixed-citation xml:lang="en">Shyam R, Gorusupudi A, Nelson K. Horvath MP. Bernstein PS. RPE65 has an additional function as the lutein to meso-zeaxanthin isomerase in the vertebrate eye. Proc. Natl. Acad. Sci. USA. 2017;114:10882–10887.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Investig. Ophthalmol. Vis. Sci. 1988;29:843–849.</mixed-citation><mixed-citation xml:lang="en">Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Investig. Ophthalmol. Vis. Sci. 1988;29:843–849.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein PS, Arunkumar R. The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. J. Lipid Res. 2021;62:100038.</mixed-citation><mixed-citation xml:lang="en">Bernstein PS, Arunkumar R. The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. J. Lipid Res. 2021;62:100038.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Малахова АИ, Ершов АВ, Быстревская АА. Потребление с пищей веществ, необходимых для функционирования сетчатки, детьми и подростками и современные возможности нутрицевтической поддержки органа зрения у детей. Клиническая офтальмология. 2025;25(1):71–77. doi: 10.32364/2311-7729-2025-25-1-11.</mixed-citation><mixed-citation xml:lang="en">Malakhova AI, Ershov AV, Bystrevskaya AA. Dietary intake of substances necessary for the functioning of the retina by children and adolescents and modern possibilities of nutraceutical support of the visual organ in children. Clinical ophthalmology. 2025;25(1):71–77. doi: 10.32364/2311-7729-2025-25-1-11.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Jia YP, Sun L, Yu HS, Liang LP, Li W, Ding H, Song XB, Zhang LJ. The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. Molecules. 2017 Apr 20;22(4):610. doi: 10.3390/molecules22040610.</mixed-citation><mixed-citation xml:lang="en">Jia YP, Sun L, Yu HS, Liang LP, Li W, Ding H, Song XB, Zhang LJ. The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. Molecules. 2017 Apr 20;22(4):610. doi: 10.3390/molecules22040610.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Widomska J, Subczynski WK, Welc-Stanowska R, Luchowski R. An Overview of Lutein in the Lipid Membrane. Int. J. Mol. Sci. 2023;24:12948. doi: 10.3390/ijms241612948.</mixed-citation><mixed-citation xml:lang="en">Widomska J, Subczynski WK, Welc-Stanowska R, Luchowski R. An Overview of Lutein in the Lipid Membrane. Int. J. Mol. Sci. 2023;24:12948. doi: 10.3390/ijms241612948.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lin CW, Yang CM, Yang CH. Effects of the Emitted Light Spectrum of Liquid Crystal Displays on Light-Induced Retinal Photoreceptor Cell Damage. Int J Mol Sci. 2019 May 10;20(9):2318.</mixed-citation><mixed-citation xml:lang="en">Lin CW, Yang CM, Yang CH. Effects of the Emitted Light Spectrum of Liquid Crystal Displays on Light-Induced Retinal Photoreceptor Cell Damage. Int J Mol Sci. 2019 May 10;20(9):2318.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Гндоян ИА. Вопросы трофической поддержки в детской офтальмологии. Офтальмология. 2020;17(3):309–320.</mixed-citation><mixed-citation xml:lang="en">Gndoyan IA. Issues of trophic support in pediatric ophthalmology. Ophthalmology. 2020;17(3):309–320 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts JE, Dennison J. The Photobiology of Lutein and Zeaxanthin in the Eye. J Ophthalmol 2015;2015:687173.</mixed-citation><mixed-citation xml:lang="en">Roberts JE, Dennison J. The Photobiology of Lutein and Zeaxanthin in the Eye. J Ophthalmol 2015;2015:687173.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Truscott TG. Synergistic effects of antioxidant vitamins. Bibliotheca Nutritio et Dieta. 2001;55:68–79.</mixed-citation><mixed-citation xml:lang="en">Truscott TG. Synergistic effects of antioxidant vitamins. Bibliotheca Nutritio et Dieta. 2001;55:68–79.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts JE, Dennison J. The photobiology of lutein and zeaxantin in the eye. Review article. J Ophthalmol. 2015:2015:687173.</mixed-citation><mixed-citation xml:lang="en">Roberts JE, Dennison J. The photobiology of lutein and zeaxantin in the eye. Review article. J Ophthalmol. 2015:2015:687173.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Scripsema NK, Hu DN, Rosen RB. Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease. J Ophthalmol. 2015;2015:865179. doi: 10.1155/2015/865179.</mixed-citation><mixed-citation xml:lang="en">Scripsema NK, Hu DN, Rosen RB. Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease. J Ophthalmol. 2015;2015:865179. doi: 10.1155/2015/865179.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Neelam K, Hogg RE, Stevenson MR, Johnston E, Anderson R, Beatty S, Chakravarthy U. Carotenoids and co-antioxidants in age-related maculopathy: design and methods. Ophthalmic Epidemiology. 2008;15:389–401.</mixed-citation><mixed-citation xml:lang="en">Neelam K, Hogg RE, Stevenson MR, Johnston E, Anderson R, Beatty S, Chakravarthy U. Carotenoids and co-antioxidants in age-related maculopathy: design and methods. Ophthalmic Epidemiology. 2008;15:389–401.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Jaggi D. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) — A pilot study. Clinical Nutrition ESPEN. 2023;56:127–134.</mixed-citation><mixed-citation xml:lang="en">Jaggi D. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) — A pilot study. Clinical Nutrition ESPEN. 2023;56:127–134.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Jia YP, Sun L, Yu HS, Liang LP, Li W, Ding H, Song XB, Zhang LJ. The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. Molecules. 2017 Apr 20;22(4):610. doi: 10.3390/molecules22040610.</mixed-citation><mixed-citation xml:lang="en">Jia YP, Sun L, Yu HS, Liang LP, Li W, Ding H, Song XB, Zhang LJ. The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. Molecules. 2017 Apr 20;22(4):610. doi: 10.3390/molecules22040610.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Berrow EJ, Bartlett HE, Eperiesi F, Gibson JM. The electroretinogram: a useful tool for evaluating age-related macular disease? Doc Ophthalmol. 2010;121(1):51–62. doi: 10.1007/s10633-010-9226-1.</mixed-citation><mixed-citation xml:lang="en">Berrow EJ, Bartlett HE, Eperiesi F, Gibson JM. The electroretinogram: a useful tool for evaluating age-related macular disease? Doc Ophthalmol. 2010;121(1):51–62. doi: 10.1007/s10633-010-9226-1.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995 Jan;36(1):182–191.</mixed-citation><mixed-citation xml:lang="en">Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995 Jan;36(1):182–191.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng AS, Vingrys AJ. Visual losses in early age-related maculopathy. Optom Vis Sci. 1993 Feb;70(2):89–96. doi: 10.1097/00006324-199302000-00001.</mixed-citation><mixed-citation xml:lang="en">Cheng AS, Vingrys AJ. Visual losses in early age-related maculopathy. Optom Vis Sci. 1993 Feb;70(2):89–96. doi: 10.1097/00006324-199302000-00001.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000 Sep;19(5):607–646. doi: 10.1016/s1350-9462(00)00013-6.</mixed-citation><mixed-citation xml:lang="en">Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000 Sep;19(5):607–646. doi: 10.1016/s1350-9462(00)00013-6.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Hood DC, Odel JG, Chen CS, Winn BJ. The multifocal electroretinogram. J Neuroophthalmol. 2003;23(3):225–235. doi: 10.1097/00041327-200309000-00008.</mixed-citation><mixed-citation xml:lang="en">Hood DC, Odel JG, Chen CS, Winn BJ. The multifocal electroretinogram. J Neuroophthalmol. 2003;23(3):225–235. doi: 10.1097/00041327-200309000-00008.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2012;124(1):1–13. doi: 10.1007/s10633-011-9296-8.</mixed-citation><mixed-citation xml:lang="en">Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2012;124(1):1–13. doi: 10.1007/s10633-011-9296-8.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Moschos MM, Nitoda E. The Role of mf-ERG in the Diagnosis and Treatment of Age-Related Macular Degeneration: Electrophysiological Features of AMD. Semin Ophthalmol. 2018;33(4):461–469. doi: 10.1080/08820538.2017.1301496.</mixed-citation><mixed-citation xml:lang="en">Moschos MM, Nitoda E. The Role of mf-ERG in the Diagnosis and Treatment of Age-Related Macular Degeneration: Electrophysiological Features of AMD. Semin Ophthalmol. 2018;33(4):461–469. doi: 10.1080/08820538.2017.1301496.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Z, Ayton LN, Guymer RH, Luu CD. Comparison between multifocal electroretinography and microperimetry in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014 Aug 26;55(10):6431–6439. doi: 10.1167/iovs.14-14407.</mixed-citation><mixed-citation xml:lang="en">Wu Z, Ayton LN, Guymer RH, Luu CD. Comparison between multifocal electroretinography and microperimetry in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014 Aug 26;55(10):6431–6439. doi: 10.1167/iovs.14-14407.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Borrelli E, Mastropasqua R, Senatore A, Palmieri M, Toto L, Sadda SR, Mastropasqua L. Impact of choriocapillaris flow on multifocal electroretinography in intermediate age-related macular degeneration eyes. Invest Ophthalmol Vis Sci. 2018;59(4):AMD25–AMD30. doi: 10.1167/iovs.18-23943.</mixed-citation><mixed-citation xml:lang="en">Borrelli E, Mastropasqua R, Senatore A, Palmieri M, Toto L, Sadda SR, Mastropasqua L. Impact of choriocapillaris flow on multifocal electroretinography in intermediate age-related macular degeneration eyes. Invest Ophthalmol Vis Sci. 2018;59(4):AMD25–AMD30. doi: 10.1167/iovs.18-23943.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Шамшинова АМ, Сеидова С-ФГ. Оптимизация методики регистрации мультифокальной электроретинограммы. Вестник офтальмологии. 2009;125(1):13–17.</mixed-citation><mixed-citation xml:lang="en">Shamshinova AM, Seidova S-FG. Optimization of the method of registration of multifocal electroretinogram. Annales of ophthalmology. 2009;125(1):13–17 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Gerth C, Hauser D, Delahunt PB, Morse LS, Werner JS. Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol. 2003;121(10):1404–1414. doi: 10.1001/archopht.121.10.1404.</mixed-citation><mixed-citation xml:lang="en">Gerth C, Hauser D, Delahunt PB, Morse LS, Werner JS. Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol. 2003;121(10):1404–1414. doi: 10.1001/archopht.121.10.1404.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Gerth C, Delahunt PB, Alam S, Morse LS, Werner JS. Conemediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term followup. Arch Ophthalmol. 2006;124(3):345–352. doi: 10.1001/archopht.124.3.345.</mixed-citation><mixed-citation xml:lang="en">Gerth C, Delahunt PB, Alam S, Morse LS, Werner JS. Conemediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term followup. Arch Ophthalmol. 2006;124(3):345–352. doi: 10.1001/archopht.124.3.345.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Tso MO, Lam TT. Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br J Ophthalmol. 2001;85(3):287–290. doi: 10.1136/bjo.85.3.287.</mixed-citation><mixed-citation xml:lang="en">Li J, Tso MO, Lam TT. Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br J Ophthalmol. 2001;85(3):287–290. doi: 10.1136/bjo.85.3.287.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Parisi V, Ziccardi L, Costanzo E, Tedeschi M, Barbano L, Manca D, Di Renzo A, Giorno P, Varano M, Parravano M. Macular functional and morphological changes in intermediate age-related maculopathy. Invest Ophthalmol Vis Sci.2020;61(5):11. doi: 10.1167/iovs.61.5.11.</mixed-citation><mixed-citation xml:lang="en">Parisi V, Ziccardi L, Costanzo E, Tedeschi M, Barbano L, Manca D, Di Renzo A, Giorno P, Varano M, Parravano M. Macular functional and morphological changes in intermediate age-related maculopathy. Invest Ophthalmol Vis Sci.2020;61(5):11. doi: 10.1167/iovs.61.5.11.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Зольникова ИВ, Карлова ИЗ, Пономарева ЕН, Виадро ЕВ, Шамшинова АМ. Макулярная и мультифокальная электроретинография в оценке функционального состояния макулярной области сетчатки при возрастной макулярной дегенерации. Вестник офтальмологии. 2009;125(1):27–32.</mixed-citation><mixed-citation xml:lang="en">Zolnikova IV, Karlova IZ, Ponomareva EN, Viadro EV, Shamshinova AM. Macular and multifocal electroretinography in assessing the functional state of the macular region of the retina in age-related macular degeneration. Annales of Ophthalmology. 2009;125(1):27–32 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Garcıa E, Vilela C, Navea A, Arnal E, Muriach M, Romero FJ. Electrophysiological and clinical tests in dry age-related macular degeneration follow-up: differences between mfERG and OCT. Doc Ophthalmol. 2016;133:31–39. doi: 10.1007/s10633-016-9545-y.</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Garcıa E, Vilela C, Navea A, Arnal E, Muriach M, Romero FJ. Electrophysiological and clinical tests in dry age-related macular degeneration follow-up: differences between mfERG and OCT. Doc Ophthalmol. 2016;133:31–39. doi: 10.1007/s10633-016-9545-y.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Ambrosio L, Ambrosio G, Nicoletti G, de Crecchio G, Falsini B. The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD. Doc Ophthalmol. 2015 Oct;131(2):125–135. doi: 10.1007/s10633-015-9507-9.</mixed-citation><mixed-citation xml:lang="en">Ambrosio L, Ambrosio G, Nicoletti G, de Crecchio G, Falsini B. The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD. Doc Ophthalmol. 2015 Oct;131(2):125–135. doi: 10.1007/s10633-015-9507-9.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S, CARMIS Study Group. Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmol. 2008;115(2):324–333. doi: 10.1016/j.ophtha.2007.05.029.</mixed-citation><mixed-citation xml:lang="en">Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S, CARMIS Study Group. Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmol. 2008;115(2):324–333. doi: 10.1016/j.ophtha.2007.05.029.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Дракон АК, Шелудченко ВМ, Юсеф ЮН, Кургузова АГ, Смирнова ТВ, Корчажкина НБ. Возможности применения физиотерапевтических технологий в офтальмореабилитации пациентов с неэкссудативной формой возрастной макулярной дегенерации (друзы). Вестник офтальмологии. 2022;138(5):74–79. doi: 10.187116/oftalma202213805174.</mixed-citation><mixed-citation xml:lang="en">Drakon AK, Sheludchenko VM, Yusef YuN, Kurguzova AG, Smirnova TV, Korchazhkina NB. Possibilities of using physiotherapeutic technologies in ophthalmic rehabilitation of patients with non-exudative form of age-related macular degeneration (drusen). Bulletin of ophthalmology. 2022;138(5):74–79 (In Russ.). doi: 10.187116/oftalma202213805174.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Moulard M, Cosker E, Angioi-Duprez K, Laprévote V, Schwan R, Schwitzer T. Retinal markers of therapeutic responses in major depressive disorder: Effects of antidepressants on retinal function. J Psychiatr Res. 2022 Oct;154:71–79. doi: 10.1016/j.jpsychires.2022.07.022.</mixed-citation><mixed-citation xml:lang="en">Moulard M, Cosker E, Angioi-Duprez K, Laprévote V, Schwan R, Schwitzer T. Retinal markers of therapeutic responses in major depressive disorder: Effects of antidepressants on retinal function. J Psychiatr Res. 2022 Oct;154:71–79. doi: 10.1016/j.jpsychires.2022.07.022.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trialof high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-relatedmacular degeneration and vision loss: AREDS report no. 8. Archives of ophthalmology. 2001;119(10):1417.</mixed-citation><mixed-citation xml:lang="en">Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trialof high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-relatedmacular degeneration and vision loss: AREDS report no. 8. Archives of ophthalmology. 2001;119(10):1417.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S; CARMIS Study Group. Carotenoids and Antioxidants in Age-Related Maculopathy Italian Study Ophthalmology. 2008 Feb;115(2):324–333.e2. doi: 10.1016/j.ophtha.2007.05.029.</mixed-citation><mixed-citation xml:lang="en">Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S; CARMIS Study Group. Carotenoids and Antioxidants in Age-Related Maculopathy Italian Study Ophthalmology. 2008 Feb;115(2):324–333.e2. doi: 10.1016/j.ophtha.2007.05.029.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Гомон ЮМ, Колбин АС, Лаврова ВА, Незнанов НГ. Фармакоэпидемиология антидепрессантов в Российской Федерации. MyRWD. 2025:1. URL: https://cyberleninka.ru/article/n/farmakoepidemiologiya-antidepressantov-v-rossiyskoyfederatsii (дата обращения: 23.06.2025).</mixed-citation><mixed-citation xml:lang="en">Gomon YuM, Kolbin AS, Lavrova VA, Neznanov N.G. Pharmacoepidemiology of antidepressants in the Russian Federation. MyRWD. 2025;1. URL: https://cyberleninka.ru/article/n/farmakoepidemiologiya-antidepressantov-v-rossiyskoy-federatsii (date of access: 06.23.2025).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
